Lab to Lives
by Ivanna Rosendal
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇮🇳IN · Life Sciences#1311K to 10K
- 🇵🇱PL · Life Sciences#993K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2K to 10K🎙 ~2x weekly·92 episodes·Last published 2d ago - Monthly Reach
Unique listeners across all episodes (30 days)
4K to 20K🇮🇳50%🇵🇱50% - Active Followers
Loyal subscribers who consistently listen
1.2K to 6K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHost
Recent guests
Recent episodes
Pharma Wants A Cupcake But Gets Ingredients w/ Dr. Isabelle Widmer
Sep 2, 2026
47m 06s
Enabling Clinical Trial Technology that Cuts Risk and Speeds Patient Access
Aug 26, 2026
45m 10s
The Emperor’s Naked And The Trial’s Still On w/ Dr. Grant Coren
Jul 8, 2026
1h 05m 59s
What If The Real Blocker Is Coordination Not Data w/ Anastasia Christianson
Jun 10, 2026
51m 40s
Electrifying the Factory: Agentic AI For Faster Clinical Trials with Pamela Tenaerts
May 13, 2026
49m 02s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 9/2/26 |  Pharma Wants A Cupcake But Gets Ingredients w/ Dr. Isabelle Widmer | Send us Fan Mail Pharma doesn’t usually fail because the science is too hard. It stalls because humans are trying to do hard work inside a system that is overloaded, siloed and full of unwritten rules. We sit down with Isabelle, a physician with deep pharma experience who now works as a consultant, to unpack what really stops transformation and what actually helps teams move again. We talk about the five big value streams in a pharma company and why the friction between them becomes th... | 47m 06s | ||||||
| 8/26/26 |  Enabling Clinical Trial Technology that Cuts Risk and Speeds Patient Access | Send us Fan Mail Clinical trials are meant to generate evidence, not paperwork, but too many studies still depend on spreadsheets, duplicate data entry and unconnected systems. This episode we are joined by Karen Maduschke, a clinical trial technology leader with over 20 years of experience, from building one of the first interactive e-consent products to scaling trial tech through acquisition and entry into a global CRO environment. Together we explore one of most pressing challenges i... | 45m 10s | ||||||
| 7/8/26 | pharmaceutical ethicspatient care+3 | Dr. Grant Coren | pharmaceutical industrybiotech | — | patients firstpharmaceutical ethics+3 | — | 1h 05m 59s | ||
| 6/10/26 | AI in pharmaclinical trials+3 | Anastasia Christianson | PfizerEPAM Life Science Consulting | — | AIpharma+4 | — | 51m 40s | ||
| 5/13/26 | clinical trialsagentic AI+3 | Pamela Tenaerts | agentic AIclinical trial system+3 | — | clinical trialsagentic AI+3 | — | 49m 02s | ||
| 4/15/26 | pharmaceutical commercializationhealthcare incentives+3 | Anish Shindore | Big Pharmapharmaceutical industry | — | pharmaceuticalscommercialization+5 | — | 1h 09m 21s | ||
| 3/30/26 | biotechpatient impact+3 | AlexDimitri | — | — | biotechpatient impact+5 | — | 48m 51s | ||
| 3/3/26 | patient engagementclinical trials+4 | Mark Duman | Pharma | — | patient engagementclinical trials+4 | — | 25m 04s | ||
| 2/11/26 | audit trailsRBQM+4 | Ellis HirokiNechama Katan | Study OSsiteroAI+2 | — | audit trailsRBQM+7 | — | 38m 45s | ||
| 1/28/26 | clinical researchpatient recruitment+3 | Caroline Potts | MRN | — | clinical trialspatient engagement+3 | — | 20m 38s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 12/17/25 | cystic fibrosistherapies+3 | two leaders from Sionna Therapeutics | Sionna TherapeuticsGenzyme+2 | — | cystic fibrosisCFTR function+3 | — | 31m 05s | ||
| 12/3/25 | AI in writingclinical trials+3 | Bilal Bham | — | — | AIclinical trials+5 | — | 24m 12s | ||
| 11/19/25 | griefadvocacy+4 | Christian John Lillis | Peggy Lillis FoundationC. diff | — | C. diffinfectious diseases+5 | — | 30m 37s | ||
| 9/10/25 | real-world evidencehealthcare research+3 | Manfred Stapff | 21st Century Cures Act | — | real-world evidencehealthcare+3 | — | 31m 13s | ||
| 8/27/25 | drug developmentAI+4 | Ilya Burkov | NebiusCloud computing | — | drug discoveryAI-driven+3 | — | 19m 56s | ||
| 8/13/25 |  Incorruptible Evidence: Blockchain's Promise for Faster Drug Approvals w. Dominik Lysek | Send us Fan Mail Dominik Lysek, CEO of PharmaTrail, explains how blockchain technology can solve trust issues in clinical trials by providing an incorruptible audit trail that verifies data integrity. This solution could significantly accelerate the time required for regulatory approvals, partnerships, and acquisitions, ultimately getting treatments to patients faster. • Blockchain provides a complete, unchangeable audit trail where data can only be added, never deleted • Most clinical data ... | 29m 09s | ||||||
| 7/30/25 |  Revolutionizing Dentistry: AI and Research Innovation with Dr. Shervin Molayem | Send us Fan Mail Dr. Shervin Molayem shares his journey of innovation in dentistry, starting with his discovery of a connection between periodontal disease and COVID-19 severity that became the world's most-read dental article of 2020. He discusses groundbreaking technologies including AI-powered diagnostic tools and a revolutionary non-surgical treatment that regenerates bone tissue around teeth. • Discovered connection between gum disease and COVID-19 severity through interleukin-6 levels ... | 40m 12s | ||||||
| 7/2/25 |  How early diagnostics of lung cancer can lead to better survival rates with Chris Wood | Send us Fan Mail Chris Wood discusses how early diagnostics of lung cancer through artificial intelligence and medical imaging can lead to better survival rates through early intervention. • Lung cancer takes more lives than breast, prostate and colon cancer combined, with approximately 70% of cases caught at late stages • The National Lung Screening Trial showed that screening high-risk populations reduced mortality by 20% • I-ELCAP research demonstrated an 80% twenty-year survival ra... | 38m 24s | ||||||
| 6/18/25 |  From Hopeless to High-Performing: Transforming Pharma Teams with Rajesh Anandan and Nechama Katan | Send us Fan Mail Building high-performing teams in life sciences requires understanding how neurodiversity can be an advantage and designing work systems that enable different brain types to collaborate effectively. • A high-performing team continues to function when everything around it has fallen apart • Star players can become crutches that mask underlying team issues • Life sciences faces unique challenges: financial pressures, outdated technology, layoffs, and pervasive lack of trust • ... | 55m 00s | ||||||
| 6/4/25 |  Data Governance in the Age of Generative AI with Sebastian Andruszczak | Send us Fan Mail Sebastian Andruszczak, Chief Growth Officer at Holisticon (part of the Nexer Group), brings fresh perspective to the conversation around generative AI adoption in pharmaceutical companies. Drawing from his unique background in sales, marketing, and technology, Sebastian cuts through the hype to address fundamental challenges that prevent successful AI implementation in life sciences. The conversation reveals a critical insight often overlooked in the rush to adopt new techno... | 37m 32s | ||||||
| 5/21/25 |  Prevention Pays: How Technology Is Revolutionizing Mental Health with Eva Papadopoulou | Send us Fan Mail Why do we wait until we're severely unwell before seeking help? In this thought-provoking episode, I'm joined by Eva Papadopoulou, a mental health professional and expert in digital and AI-enabled healthcare solutions, to explore the transformative potential of preventative mental healthcare. Eva reveals the stark reality of our current healthcare systems - less than 10% of budgets are allocated to prevention, despite evidence showing preventative approaches lead to better o... | 28m 38s | ||||||
| 4/23/25 |  Creating virtuous cycles in drug development with Rob Freishtat | Send us Fan Mail Rob Freistat, President of Uncommon Cures, discusses how clinical trials are transforming to accelerate drug development and ensure patients receive treatments faster, particularly in the rare disease space. • Current market uncertainty and investment challenges in biotech, especially for rare disease research • Approximately two-thirds of clinical trial processes add no value and aren't required by regulations • Many clinical trial failures occur not because drugs don't wor... | 46m 38s | ||||||
| 4/9/25 |  Bridging Academia and Biotech: Creating Innovators of Tomorrow with Jonathon Hill | Send us Fan Mail Jonathan Hill takes us on a fascinating journey through the cutting-edge world of DNA sequencing and its revolutionary potential for early disease detection. As both an academic professor at Brigham Young University and co-founder of Wasatch BioLabs, Hill shares how third-generation sequencing technologies are transforming our ability to identify diseases years before symptoms appear. The conversation centers on a groundbreaking approach using native methylation calling—a me... | 33m 27s | ||||||
| 3/26/25 |  From Lab to Patient: Why Vector Design Makes or Breaks Cell Therapies with Alan Griffith | Send us Fan Mail Vectors are the unsung heroes of cell and gene therapy—molecular couriers that transport therapeutic genes into human cells to treat disease. But as Alan Griffith, Head of Global Operations at Vector Builder reveals, creating these sophisticated delivery vehicles is far more complex than most realize. Drawing from over a decade of experience developing gene therapies before joining the CDMO sector, Griffith offers rare insight into what makes manufacturing these therapies so... | 57m 47s | ||||||
| 3/12/25 |  Tomorrow's Cures Are Hiding in Today's Patient Records with Vish Srivastava | Send us Fan Mail The untapped potential of electronic health records has long been recognized in clinical research, but extracting meaningful insights from this treasure trove of data has remained an elusive challenge—until now. Vish Srivastava, founder of Century Health, reveals how artificial intelligence is revolutionizing real-world evidence by unlocking critical patient data trapped in EHRs. Traditional patient registries that once took a decade to amass just 1,000 patients can now be c... | 25m 42s | ||||||
Showing 25 of 97
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Lab to Lives
Peaked at #99 in PL, currently #99 in PL.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| PL | — | #99 | #99 | — |
| India | — | #131 | #131 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.